Stocks to buy in 2025 for long term: Cohance Lifesciences, Divi’s Lab among 5 stocks that could give 10-30% return – Brokerage Recommendations

Choice Institutional Equities on Senores Pharma Ltd: Buy| Target Rs 960| LTP Rs 723| Upside 32%

Choice Institutional Equities has initiated coverage on Senores Pharma with a Buy rating and a target price of Rs 960. Given the current market price of Rs 723, the brokerage foresees an upside of 32%.

(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)